Tissue Regenix Group plc announced that the first order of its allograft products has been shipped from its third-party Irish logistics hub, Biostor Ireland Ltd, following approval from the Irish Health Products Regulatory Authority in October 2023. The Irish logistics hub provides a central European location for the distribution of Tissue Regenix's allograft products throughout the European Union ('EU'), facilitating increased shipments across the EU and aiding the potential for further partnerships and distributor contracts within these countries. Tissue Regenix also announces that it has signed two new distributor agreements for its allograft products in Turkey and Ireland (including Northern Ireland).

These agreements cover the dental and orthopaedic markets and continue the expansion of the Company's EU coverage, following the recently announced exclusive distributor agreement in Spain with Spineart Espana SLU. These developments are in line with the Group's commercial strategy of expanding its distribution network and growing market share in other jurisdictions outside the US in second half of 2023.